Abstract
Glioblastoma (GBM),IV astrocytoma (WHO), primary brain tumor is the most frequent malignant in adults. A tumor characterized by being highly resistant to therapy, and since the poor prognosis of patients with glioblastomas and current treatment, new therapeutic approaches are needed. One attractive approach is the use of specific tumor antigens as targets to stimulate the patient's immune…